Arch Biopartners Inc.
ACHFF · OTC
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $111,436 | $68,681 | $187,365 | $105,714 |
| - Cash | $3 | $831 | $506 | $448 |
| + Debt | $2,770 | $5,016 | $4,413 | $5,164 |
| Enterprise Value | $114,203 | $72,865 | $191,271 | $110,429 |
| Revenue | $2,122 | $1,984 | $965 | $3,887 |
| % Growth | 7% | 105.7% | -75.2% | – |
| Gross Profit | -$1,656 | -$129 | -$503 | -$150 |
| % Margin | -78% | -6.5% | -52.1% | -3.9% |
| EBITDA | $0 | -$2,980 | -$1,080 | -$892 |
| % Margin | 0% | -150.2% | -112% | -22.9% |
| Net Income | -$3,920 | -$3,327 | -$1,408 | -$1,170 |
| % Margin | -184.7% | -167.7% | -146% | -30.1% |
| EPS Diluted | -0.062 | -0.053 | -0.023 | -0.019 |
| % Growth | -15.9% | -134.8% | -18.8% | – |
| Operating Cash Flow | -$2,331 | -$234 | $479 | -$2,981 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2,331 | -$234 | $479 | -$2,981 |